![Noaman Akhtar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Noaman Akhtar
Director Técnico/Científico/I+D en
Aavantibio, Inc.
.
Perfil
Noaman Akhtar is currently the Vice President & Head-Clinical Operations at Aavantibio, Inc. Previously, he held the position of Senior Director-Clinical Operations at Editas Medicine, Inc. and Vice President & Head-Clinical Operations at Synlogic, Inc. He completed his undergraduate degree at the University of Karachi.
Cargos activos de Noaman Akhtar
| Empresas | Cargo | Inicio |
|---|---|---|
Aavantibio, Inc.
 Aavantibio, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops new gene therapies | Director Técnico/Científico/I+D | - |
Antiguos cargos conocidos de Noaman Akhtar.
| Empresas | Cargo | Fin |
|---|---|---|
| EDITAS MEDICINE, INC. | Director Técnico/Científico/I+D | 01/01/2022 |
| SYNLOGIC, INC. | Director Técnico/Científico/I+D | - |
Formación de Noaman Akhtar.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
6
Relaciones de 1er grado
4
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
University of Karachi
 University of Karachi Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Editas Medicine, Inc.
 Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
Synlogic, Inc.
 Synlogic, Inc. Financial ConglomeratesFinance Operates as a shell company | Finance |
Aavantibio, Inc.
Aavantibio, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops new gene therapies | Health Technology |
- Bolsa de valores
- Insiders
- Noaman Akhtar
